Relafen its generic form 750, viewed analyzed from a biochemical molecular pharmacy perspective, represents a compelling or interesting illustration of NSAID or non-copyrightal anti-inflammatory drug action. Its mechanism or mode involves primarily substantially inhibiting cyclooxygenase prostaglandin synthetase , specifically COX-2, thereby reduci